amphetamine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (29.17) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Conway, SJ; Ganapathy, V; Huang, W; Leibach, FH; Prasad, PD; Rajan, DP; Seth, P; Wu, X | 1 |
| Corsini, GU; Del Zompo, M; Piccardi, MP; Ruiu, S; Vaccari, A | 1 |
| Fung, YK; Troxel, CE | 1 |
| Damsma, G; de Vries, JB; Horn, AS; Kranenborg, GL; Kuhr, WG; Rollema, H; Westerink, BH | 1 |
| Rhind, AW; Steranka, LR | 1 |
| Fuller, RW; Steranka, LR | 1 |
| Cohen, O; Globus, M; Melamed, E; Rosenthal, J; Uzzan, A | 1 |
| Andrews, JS; Biggins, JA; Candy, JM; Edwardson, JA; Keith, AB; Sahgal, A; Turner, JD; Wright, C | 1 |
| Boyce, S; Jenner, P; Kelly, E; Marsden, CD; Reavill, C | 1 |
| Boulton, AA; Davis, BA; Yu, PH | 1 |
| Del Zompo, M; Gessa, GL; Piccardi, MP; Quartu, M; Ruiu, S; Vaccari, A | 1 |
| Budai, G; Kardos, V; Pátfalusi, M; Patthy, M; Sziráki, I | 1 |
| Ghetti, B; Richter, JA; Simon, JR | 1 |
| Boulton, AA; Davis, BA; Fang, J; Lai, CT; Li, XM; Paterson, IA; Yu, PH; Zhang, X; Zuo, DM | 1 |
| Barnéoud, P; Boireau, A; Doble, A; Dubédat, P; Mazadier, M; Miquet, JM; Parmentier, S | 1 |
| Wu, WR; Zhu, XZ | 1 |
| Chancy, CD; Ganapathy, V; Huang, W; Kekuda, R; Rajan, PD; Smith, SB | 1 |
| Caron, MG; Cory-Slechta, DA; Di Monte, DA; Federoff, HJ; Gainetdinov, RR; Richfield, EK; Thiruchelvam, MJ; Wuertzer, C | 1 |
| Brownell, AL; Chen, YC; Isacson, O; Jenkins, BG; Sanchez-Pernaute, R | 1 |
| Büeler, H; Dong, Z; Lipp, HP; Wolfer, DP | 1 |
| Billinton, A; Brown, M; Chapman, H; Quinn, LP; Stean, TO; Upton, N; Vidgeon-Hart, M; Virley, DJ | 1 |
| Kurz, MJ; Lau, YS; Pothakos, K | 1 |
| Bordia, T; Huang, LZ; Michael McIntosh, J; Parameswaran, N; Quik, M | 1 |
| Bortolanza, M; Brandão, ML; Carvalho, MC; Correia, D; Da Cunha, C; Dombrowski, PA; Dos Santos, LM; Eckart, MT; Miyoshi, E; Schwarting, RK; Wietzikoski, EC | 1 |
2 review(s) available for amphetamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Aliphatic propargylamines, a new series of potent selective, irreversible non-amphetamine-like MAO-B inhibitors. Their structures, function and pharmacological implications.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Mice; Monoamine Oxidase Inhibitors; Pargyline; Propylamines; Structure-Activity Relationship | 1995 |
Neurochemical, neuroprotective and neurorescue effects of aliphatic N-methylpropargylamines; new MAO-B inhibitors without amphetamine-like properties.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Cell Count; Cerebral Cortex; Hippocampus; Mice; Monoamine Oxidase Inhibitors; Rats; Selegiline | 1995 |
22 other study(ies) available for amphetamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
Topics: Acetylcarnitine; Animals; Biological Transport, Active; Carnitine; Carrier Proteins; Humans; In Situ Hybridization; Kidney; Membrane Proteins; Mice; Myocardium; Organ Specificity; Organic Cation Transport Proteins; Placenta; Rats; RNA, Messenger; Solute Carrier Family 22 Member 5; Tetraethylammonium | 1999 |
High-affinity binding of [3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion to mouse striatal membranes: putative vesicular location.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Binding, Competitive; Corpus Striatum; Dopamine; In Vitro Techniques; Melanins; Membranes; Mice; Monoamine Oxidase; Nerve Endings; Tyramine | 1991 |
Amphetamine-induced circling behaviour in MPTP-lesioned mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Corpus Striatum; Dextroamphetamine; Dopamine; Male; Mice; Mice, Inbred ICR; Pyridines; Stereotyped Behavior | 1985 |
The use of in vivo brain dialysis of dopamine, acetylcholine, amino acids and lactic acid in studies on the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 2,4-Dinitrophenol; Acetylcholine; Amino Acids; Amphetamine; Animals; Brain; Dialysis; Dinitrophenols; Dopamine; Lactates; Lactic Acid; Pyridines; Pyridinium Compounds; Rats | 1988 |
Effect of cysteine on the persistent depletion of brain monoamines by amphetamine, p-chloroamphetamine and MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Amphetamines; Animals; Biogenic Amines; Corpus Striatum; Cysteine; Dopamine; Iprindole; Male; p-Chloroamphetamine; Pyridines; Rats; Rats, Inbred Strains; Serotonin | 1987 |
Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Brain; Dopamine; Iprindole; Mice; Monoamine Oxidase; Myocardium; Norepinephrine; Pyridines; Rats | 1985 |
Amphetamine, but not reserpine, protects mice against dopaminergic neurotoxicity of MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Corpus Striatum; Dopamine; Mice; Mice, Inbred C57BL; Nerve Endings; Neurons; Pyridines; Receptors, Dopamine; Reserpine | 1985 |
N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects locomotor activity without producing a nigrostriatal lesion in the rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Apomorphine; Corpus Striatum; Depression, Chemical; Disease Models, Animal; Male; Motor Activity; Neural Pathways; Parkinson Disease; Pyridines; Rats; Rats, Inbred Strains; Substantia Nigra | 1984 |
Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Apomorphine; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Motor Activity; Neurons; Pyridines; Rats; Rats, Inbred Strains | 1984 |
Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Biomarkers; Brain; Corpus Striatum; Dopamine; Dopamine Agents; In Vitro Techniques; Male; Mice; Microscopy, Electron; MPTP Poisoning; Nervous System Diseases; Pyridinium Compounds; Synaptic Vesicles; Tetrabenazine | 1993 |
Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Brain Diseases; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons | 1994 |
Dopamine-depleting effects of MPTP and reserpine in weaver mutant mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Cytoplasm; Dopamine; Electrochemistry; Female; Heterozygote; Homozygote; Male; Mice; Mice, Neurologic Mutants; Neostriatum; Nerve Endings; Neurons; Reserpine; Subcellular Fractions; Substantia Nigra | 1993 |
Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Apomorphine; Brain Chemistry; Central Nervous System Stimulants; Conditioning, Operant; Dopamine Agonists; Female; Male; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Riluzole; Stereotyped Behavior; Substantia Nigra; Sympatholytics; Thiazoles | 1996 |
The amphetamine-like reinforcing effect and mechanism of L-deprenyl on conditioned place preference in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Conditioning, Operant; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Reinforcement, Psychology; Selegiline | 1999 |
Expression of the extraneuronal monoamine transporter in RPE and neural retina.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Biogenic Monoamines; Blotting, Northern; Carrier Proteins; Cells, Cultured; Eye; Female; Gene Expression; Humans; Hydrogen-Ion Concentration; In Situ Hybridization; Kinetics; Methamphetamine; Mice; Mice, Inbred ICR; Nicotine; Organic Cation Transport Proteins; Pigment Epithelium of Eye; Procainamide; Retina; RNA, Messenger; Steroids; Tetraethylammonium; Time Factors | 2000 |
Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; alpha-Synuclein; Amphetamine; Animals; Behavior, Animal; Brain; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Dopamine Plasma Membrane Transport Proteins; Genetic Predisposition to Disease; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Transgenic; Motor Activity; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Parkinson Disease; Parkinson Disease, Secondary; Presynaptic Terminals; Promoter Regions, Genetic; Substantia Nigra; Synucleins; Tyrosine 3-Monooxygenase | 2002 |
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Brain; Brain Mapping; Cerebrovascular Circulation; Cocaine; Dopamine; Dopamine Agents; Macaca fascicularis; Magnetic Resonance Imaging; Motor Activity; Parkinsonian Disorders; Positron-Emission Tomography; Radioligand Assay | 2004 |
Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Apoptosis; Behavior, Animal; Dependovirus; Disease Models, Animal; Dopamine; Genetic Therapy; HSP70 Heat-Shock Proteins; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Parkinson Disease; Substantia Nigra; Transduction, Genetic | 2005 |
Further validation of LABORAS using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Apomorphine; Automation; Behavior, Animal; Benzazepines; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Electrochemistry; Haloperidol; Hyperkinesis; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neostriatum; Nerve Degeneration; Psychology, Experimental; Reproducibility of Results; Substantia Nigra | 2006 |
Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Ataxia; Disease Models, Animal; Gait; Male; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Nerve Degeneration; Parkinson Disease; Physical Conditioning, Animal; Postural Balance; Probenecid | 2009 |
Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Analysis of Variance; Animals; Autoradiography; Cocaine; Conotoxins; Corpus Striatum; Cotinine; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Iodine Isotopes; Male; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Nicotine; Oxidopamine; Protein Binding; Rats; Rats, Sprague-Dawley; Saimiri; Substantia Nigra; Time Factors | 2009 |
Microdialysis study of striatal dopamine in MPTP-hemilesioned rats challenged with apomorphine and amphetamine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Male; Microdialysis; Rats; Rats, Wistar; Stereotyped Behavior; Video Recording | 2010 |